[1]

Fontana L, Plaza-Díaz J, Robles-Bolívar P, Valente-Godínez H, Sáez-Lara MJ, et al. 2021. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 modulate macrophage gene expression and ameliorate damage markers in the liver of Zucker-Leprfa/fa rats. Nutrients 13:202

doi: 10.3390/nu13010202
[2]

Liu L, Zhao J, Zhang R, Wang X, Wang Y, et al. 2021. Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease. Journal of Pharmaceutical and Biomedical Analysis 200:114058

doi: 10.1016/j.jpba.2021.114058
[3]

Cao X, Wang N, Yang M, Zhang C. 2025. Lipid accumulation and insulin resistance: bridging metabolic dysfunction-associated fatty liver disease and chronic kidney disease. International Journal of Molecular Sciences 26:6962

doi: 10.3390/ijms26146962
[4]

Hong JT, Lee MJ, Yoon SJ, Shin SP, Bang CS, et al. 2021. Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function. Journal of Ginseng Research 45:316−324

doi: 10.1016/j.jgr.2020.07.004
[5]

Kang Y, Kang X, Yang H, Liu H, Yang X, et al. 2022. Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability. Pharmacological Research 175:106020

doi: 10.1016/j.phrs.2021.106020
[6]

Ribatti D. 2024. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Comment. Internal and Emergency Medicine 19:1515−1516

doi: 10.1007/s11739-024-03600-z
[7]

Mohit, Maury J, Bajpai J, Verma S. 2025. Disrupted bilirubin metabolism and gut microbiome dysregulation: a link to cardio-renal-hepatic-metabolic health in obstructive sleep apnea. Life Sciences 379:e123872

doi: 10.1016/j.lfs.2025.123872
[8]

Ma J, Li Y, Yang Y, Zhao L, Jiang Y, et al. 2025. Gut-liver axis mechanisms of Hippophae rhamnoides L. in non-alcoholic fatty liver disease prevention. Phytomedicine 149:e157517

doi: 10.1016/j.phymed.2025.157517
[9]

Guo F, Chen D, Tsao R, Shahidi F, Xiong H, et al. 2024. Effects of dietary supplementation with green lentil (Lens culinaris) hulls on NAFLD: focus on intestinal and hepatic metabolism. Food Bioscience 59:103851

doi: 10.1016/j.fbio.2024.103851
[10]

Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, et al. 2021. Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: recent updates. International Journal of Biological Sciences 17:818−833

doi: 10.7150/ijbs.56214
[11]

Shen Y, Fan N, Ma SX, Cheng X, Yang X, et al. 2025. Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy. MedComm 6:e70168

doi: 10.1002/mco2.70168
[12]

Beyaz Coşkun A, Sağdiçoğlu Celep AG. 2022. Therapeutic modulation methods of gut microbiota and gut-liver axis. Critical Reviews in Food Science and Nutrition 62:6505−6515

doi: 10.1080/10408398.2021.1902263
[13]

Çakır N, Bilgiçli N, Yaver E. 2021. Impact of xylanase-treated wheat milling by-products on the physical and chemical properties of cakes. Journal of the Science of Food and Agriculture 101:6331−6337

doi: 10.1002/jsfa.11303
[14]

Zhang Y, Zhao N, Yang L, Hong Z, Cai B, et al. 2021. Insoluble dietary fiber derived from brown seaweed Laminaria japonica ameliorate obesity-related features via modulating gut microbiota dysbiosis in high-fat diet–fed mice. Food & Function 12:587−601

doi: 10.1039/d0fo02380a
[15]

Song J, Lu X, Liu D, Zhang Y, Zhai X, et al. 2023. Fucogalactan sulfate (FS) from Laminaria japonica regulates lipid metabolism in diet-induced humanized dyslipidemia mice via an intestinal FXR-FGF19-CYP7A1/CYP8B1 pathway. Journal of Agricultural and Food Chemistry 71:14027−14037

doi: 10.1021/acs.jafc.3c04683
[16]

Li D, Li Y, Yang S, Lu J, Jin X, et al. 2022. Diet-gut microbiota-epigenetics in metabolic diseases: from mechanisms to therapeutics. Biomedicine & Pharmacotherapy 153:113290

doi: 10.1016/j.biopha.2022.113290
[17]

Tong A, Li Z, Liu X, Ge X, Zhao R, et al. 2024. Laminaria japonica polysaccharide alleviates type 2 diabetes by regulating the microbiota-gut-liver axis: a multi-omics mechanistic analysis. International Journal of Biological Macromolecules 258:128853

doi: 10.1016/j.ijbiomac.2023.128853
[18]

Sawant SS, Park HY, Sim EY, Kim HS, Choi HS. 2025. Microbial fermentation in food: impact on functional properties and nutritional enhancement—a review of recent developments. Fermentation 11:15

doi: 10.3390/fermentation11010015
[19]

Tegegne BA, Kebede B. 2022. Probiotics, their prophylactic and therapeutic applications in human health development: a review of the literature. Heliyon 8:e09725

doi: 10.1016/j.heliyon.2022.e09725
[20]

Li J, Li G, Zhang H, Yang T, Abbas Z, et al. 2024. The fermentation quality, antioxidant activity, and bacterial community of mulberry leaf silage with Pediococcus, Bacillus, and wheat bran. Fermentation 10:214

doi: 10.3390/fermentation10040214
[21]

Widodo W, Kusumaningrum HRP, Wihadmadyatami H, Wicaksana AL. 2023. Milk fermented with Pediococcus acidilactici strain BE improves high blood glucose levels and pancreatic beta-cell function in diabetic rats. Korean Journal for Food Science of Animal Resources 43:170−183

doi: 10.5851/kosfa.2022.e69
[22]

Huang J, Omedi JO, Huang C, Chen C, Liang L, et al. 2024. Effect of black bean supplemented with wheat bran sourdough fermentation by Pediococcus acidilactici or Pediococcus pentosaceus on baking quality and staling characteristics of wheat composite bread. Applied Food Research 4:100425

doi: 10.1016/j.afres.2024.100425
[23]

Zhang Q, Guo WL, Chen GM, Qian M, Han JZ, et al. 2022. Pediococcus acidilactici FZU106 alleviates high-fat diet-induced lipid metabolism disorder in association with the modulation of intestinal microbiota in hyperlipidemic rats. Current Research in Food Science 5:775−788

doi: 10.1016/j.crfs.2022.04.009
[24]

Zhang Y, Liu T, Qu ZJ, Wang X, Song WG, et al. 2024. Laminaria japonica aresch-derived fucoidan ameliorates hyperlipidemia by upregulating LXRs and suppressing SREBPs. Cardiovascular Therapeutics 2024:8649365

doi: 10.1155/2024/8649365
[25]

Angel-Isaza J, Carmona-Hernandez JC, González-Correa CH, Narváez-Solarte WV. 2023. Potential hypoglycemic and antilipidemic activity of polyphenols from Passiflora ligularis (granadilla). Molecules 28:3551

doi: 10.3390/molecules28083551
[26]

McGlinchey AJ, Govaere O, Geng D, Ratziu V, Allison M, et al. 2022. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. JHEP Reports 4:100477

doi: 10.1016/j.jhepr.2022.100477
[27]

Fan X, Zhang Q, Guo W, Wu Q, Hu J, et al. 2023. The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats. Food Science and Human Wellness 12:1646−1659

doi: 10.1016/j.fshw.2023.02.021
[28]

Serdarova M, Dimova R, Chakarova N, Grozeva G, Todorova A, et al. 2022. Metabolic determinants of NAFLD in adults with type 1 diabetes. Diabetes Research and Clinical Practice 186:109819

doi: 10.1016/j.diabres.2022.109819
[29]

Juárez-Fernández M, Porras D, Petrov P, García-Mediavilla MV, Sagüillo SR, et al. 2021. A dietary intervention with Akkermansia muciniphila and quercetin supplementation reshapes gut microbiota composition in an in vivo model of early obesity related non-alcoholic fatty liver disease. Proceedings of the Nutrition Society 80:E51

doi: 10.1017/S002966512100063X
[30]

Huo J, Wu Z, Sun W, Wang Z, Wu J, et al. 2022. Protective effects of natural polysaccharides on intestinal barrier injury: a review. Journal of Agricultural and Food Chemistry 70:711−735

doi: 10.1021/acs.jafc.1c05966
[31]

Liu L, Wang Y, Zhang J, Wang C, Li Y, et al. 2023. Probiotics in treating with alcoholic liver disease and nonalcoholic fatty liver disease. Food Reviews International 39:2723−2741

doi: 10.1080/87559129.2021.1967380
[32]

Huang Y, Wang Q, Wang N, Zhang R, Zhang H, et al. 2026. Pediococcus acidilactici PA-1 alleviates diet-induced obesity by modulating hepatic amino acid metabolism and gut microbiota in mice. Probiotics and Antimicrobial Proteins 18:4746−4767

doi: 10.1007/s12602-025-10771-4
[33]

Casagrande BP, Pisani LP, Estadella D. 2021. AMPK in the gut-liver-brain axis and its influence on OP rats in an HSHF intake and WTD rat model. Pflügers Archiv-European Journal of Physiology 473:1199−1211

doi: 10.1007/s00424-021-02583-6
[34]

Huang ZR, Chen M, Guo WL, Li TT, Liu B, et al. 2020. Monascus purpureus-fermented common buckwheat protects against dyslipidemia and non-alcoholic fatty liver disease through the regulation of liver metabolome and intestinal microbiome. Food Research International 136:109511

doi: 10.1016/j.foodres.2020.109511
[35]

Tong A, Wang D, Liu X, Li Z, Zhao R, et al. 2023. The potential hypoglycemic competence of low molecular weight polysaccharides obtained from Laminaria japonica. Foods 12:3809

doi: 10.3390/foods12203809
[36]

Gao Y, Guo M, Zheng P, Liu R, Wang D, et al. 2022. Effects of sulfated polysaccharides from Laminaria japonica on regularating the gut microbiotan and alleviating intestinal inflammation in obese mice. Food and Chemical Toxicology 168:113401

doi: 10.1016/j.fct.2022.113401
[37]

Zhu C, Guan Q, Song C, Zhong L, Ding X, et al. 2021. Regulatory effects of Lactobacillus fermented black barley on intestinal microbiota of NAFLD rats. Food Research International 147:110467

doi: 10.1016/j.foodres.2021.110467
[38]

Du R, Bei H, Jia L, Huang C, Chen, Q, et al. 2020. Danggui Buxue Tang restores antibiotic-induced metabolic disorders by remodeling the gut microbiota. Journal of Ethnopharmacology 259:112953

doi: 10.1016/j.jep.2020.112953
[39]

Hu X, Chen F, Jia L, Long A, Peng Y, et al. 2024. A gut-derived hormone regulates cholesterol metabolism. Cell 187:1685−1700.e18

doi: 10.1016/j.cell.2024.02.024
[40]

Ma Z, Huang Z, Zhang C, Liu X, Zhang J, et al. 2023. Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice. Diabetologia 66:390−405

doi: 10.1007/s00125-022-05829-9
[41]

Zhang H, Li Y, Zhang C, Huang K, Zhao J, et al. 2022. B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36. Cell Death & Disease 13:359

doi: 10.1038/s41419-022-04812-x
[42]

Zhao Z, Chen L, Zhao Y, Wang C, Duan C, et al. 2020. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. Applied Microbiology and Biotechnology 104:5273−5282

doi: 10.1007/s00253-020-10633-9
[43]

Song Q, Zhang X. 2022. The role of gut–liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC. Biomedicines 10:524

doi: 10.3390/biomedicines10030524
[44]

Atasoy M, Eyice O, Cetecioglu Z. 2020. A comprehensive study of volatile fatty acids production from batch reactor to anaerobic sequencing batch reactor by using cheese processing wastewater. Bioresource Technology 311:123529

doi: 10.1016/j.biortech.2020.123529
[45]

Facchin S, Calgaro M, Savarino EV. 2025. Rethinking short-chain fatty acids: a closer look at propionate in inflammation, metabolism, and mucosal homeostasis. Cells 14:1130

doi: 10.3390/cells14151130
[46]

Zhang C, Jia J, Zhang P, Zheng W, Guo X, et al. 2022. Fucoidan from Laminaria japonica ameliorates type 2 diabetes mellitus in association with modulation of gut microbiota and metabolites in streptozocin-treated mice. Foods 12:33

doi: 10.3390/foods12010033
[47]

Hong Y, Sheng L, Zhong J, Tao X, Zhu W, et al. 2021. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. Gut Microbes 13:1930874

doi: 10.1080/19490976.2021.1930874
[48]

Wang Y, Xue Y, Xu H, Zhu Q, Qin K, et al. 2025. Pediococcus acidilactici Y01 reduces HFD-induced obesity via altering gut microbiota and metabolomic profiles and modulating adipose tissue macrophage M1/M2 polarization. Food & Function 16:554−569

doi: 10.1039/d4fo04301d
[49]

Shulpekova Y, Shirokova E, Zharkova M, Tkachenko P, Tikhonov I, et al. 2022. A recent ten-year perspective: bile acid metabolism and signaling. Molecules 27:1983

doi: 10.3390/molecules27061983
[50]

Ni Y, Lu M, Xu Y, Wang Q, Gu X, et al. 2022. The role of gut microbiota-bile acids axis in the progression of non-alcoholic fatty liver disease. Frontiers in Microbiology 13:908011

doi: 10.3389/fmicb.2022.908011
[51]

Yanai H, Adachi H, Hakoshima M, Iida S, Katsuyama H. 2023. Metabolic-dysfunction-associated steatotic liver disease—its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments. International Journal of Molecular Sciences 24:15473

doi: 10.3390/ijms242015473
[52]

Li Z, Zhao Y, Cheng J, Xu L, Wen X, et al. 2022. Integrated plasma metabolomics and gut microbiota analysis: the intervention effect of Jiawei Xiaoyao San on liver depression and spleen deficiency liver cancer rats. Frontiers in Pharmacology 13:906256

doi: 10.3389/fphar.2022.906256
[53]

Sun J, Fan J, Li T, Yan X, Jiang Y. 2022. Nuciferine protects against high-fat diet-induced hepatic steatosis via modulation of gut microbiota and bile acid metabolism in rats. Journal of Agricultural and Food Chemistry 70:12014−12028

doi: 10.1021/acs.jafc.2c04817